ClinTrials Research Names S. Colin Neill Chief Financial Officer.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Oct. 22, 1998--ClinTrials Research Inc. (Nasdaq: CCRO) today announced the appointment of S. Colin Neill, CPA, as Senior Vice President and Chief Financial Officer, effective October 22, 1998. Mr. Neill will be based in Raleigh, North Carolina and will report directly to Dr. Jerry R. Mitchell, Chairman, President and Chief Executive Officer.

Mr. Neill has more than twenty-five years of global business experience in the manufacturing, health care, biotechnology, and financial services industries. Before joining ClinTrials Research, Mr. Neill was Vice President, Chief Financial Officer of Continental Health Affiliates, Inc. (now trading Nasdaq: KUAL) and its majority owned subsidiary Infu-Tech, Inc. (Nasdaq: INFU), a network of health care companies focused on home care, long term care, assisted living and managed care. Mr. Neill's lengthy career experience has included that of Acting Vice President Finance, Chief Financial Officer of Pharmos Corporation (Nasdaq: PARS), a biopharmaceutical company in the business of developing novel drug technologies; Vice President - Finance, Chief Financial Officer of BTR Inc., the US subsidiary of BTR plc, a British diversified manufacturing company with US revenues of approximately $3.5 billion; and Vice President - Financial Services of The BOC Group, Inc., a British industrial gases company with substantial operations in the health care industry. He began his career in public accounting with Arthur Andersen LLP in Ireland as a Senior Auditor and later with Price Waterhouse LLP in New York City as a Senior Manager. Mr. Neill will be replacing Mary Chaput who has resigned as Vice President and Chief Financial Officer to pursue other interests in Nashville, TN.

Dr. Jerry R. Mitchell, Chairman, President and CEO of ClinTrials Research commented, "Mr. Neill will be a valuable addition to our management team. His vast global business experience and his extensive financial background will be a great asset to the Company and its clients. Ms. Chaput has been an integral member of ClinTrials Research senior management team and a respected colleague. She has played a significant role in addressing the issues that we have confronted over the past two years and in implementing our new business initiatives. Her assistance during the transition will be valued."

Mr. Neill graduated with first class honors from Dublin University (Trinity College) in Dublin, Ireland, earning a BBS in Business/Economics and from the London School of Economics with a M.Sc in Finance and Accounting. Mr. Neill is both a Certified Public Accountant in the State of New York and a Chartered Accountant (FCA) and a member of the Financial Executives Institute.

ClinTrials Research is a global contract research organization headquartered in Nashville, Tennessee, with offices in Research Triangle Park, North Carolina; Chicago Illinois; Maidenhead, England; Glasgow, Scotland; Brussels, Belgium; Paris, France; Melbourne, Australia; Tel Aviv, Israel; Santiago, Chile; Milan, Italy; and Montreal, Canada. With more than 1300 employees, ClinTrials Research provides comprehensive preclinical, clinical, and post-marketing research services, including monitoring, data management and biostatistics, medical and regulatory services to pharmaceutical, biotechnology and medical device clients.